NASDAQ:SABSW

Sab Biotherapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy SABSW

*Your capital is at risk

$0.0168

-0.0018 (-9.68%)

At Close: Jun 03, 2026

Sab Biotherapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 50.33M and sold 26.43K SABSW shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	50.33M shares
● Sell	26.43K shares
92% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Jul 22, 2025 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 100. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (92% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 24, 2026 Sell	Common Stock F-InKind	Kropotova Alexandra Chief Medical Officer	Officer	988 Value: $0
Feb 03, 2026 Buy	Stock option (right to buy) A-Award	To Lucy See Remarks	Officer	2 400 000 Value: $10.7M
Feb 03, 2026 Buy	Stock option (right to buy) A-Award	Kropotova Alexandra Chief Medical Officer	Officer	2 400 000 Value: $10.7M
Feb 03, 2026 Buy	Stock option (right to buy) A-Award	Sullivan Eddie Joe President	CEO / President	3 000 000 Value: $13.4M
Feb 03, 2026 Buy	Stock option (right to buy) A-Award	Reich Samuel J CEO	CEO / President	4 800 000 Value: $21.4M
Feb 03, 2026 Buy	Stock option (right to buy) A-Award	Bausch Christoph Lawrence Chief Operating Officer	C-Suite Officer	1 800 000 Value: $8.01M
Jan 05, 2026 Buy	Stock Option (right to buy) A-Award	Zaccardelli David Director	Director	240 000 Value: $897.6K
Jan 05, 2026 Buy	Stock Option (right to buy) A-Award	Jain Rita Director	Director	240 000 Value: $897.6K
Jan 05, 2026 Buy	Common Stock J-Other	Jain Rita Insider	Other	0 Value: $0
Jan 05, 2026 Buy	Common Stock J-Other	Zaccardelli David Insider	Other	0 Value: $0
Dec 16, 2025 Buy	Stock Option (right to buy) A-Award	Link David Director	Director	150 000 Value: $598.5K
Dec 16, 2025 Buy	Stock Option (right to buy) A-Award	Giberson Scott Director	Director	150 000 Value: $598.5K
Dec 16, 2025 Buy	Stock Option (right to buy) A-Award	Polvino William James Director	Director	150 000 Value: $598.5K
Dec 16, 2025 Buy	Stock Option (right to buy) A-Award	Skyler Jay S Director	Director	150 000 Value: $598.5K
Dec 16, 2025 Buy	Stock option (right to buy) A-Award	Lucera Erick Director	Director	150 000 Value: $598.5K
Dec 16, 2025 Buy	Stock Option (right to buy) A-Award	Ellias Helen K. Director	Director	150 000 Value: $598.5K
Dec 11, 2025 Sell	Common Stock F-InKind	Kropotova Alexandra Chief Medical Officer	Officer	988 Value: $0
Sep 29, 2025 Buy	Common Stock M-Exempt	Moin Andrew Director	Director	1 740 000 Value: $3.05M
Sep 29, 2025 Buy	Series B Convertible Preferred Stock M-Exempt	Moin Andrew Director	Director	17 400 Value: $30.5K
Sep 29, 2025 Buy	Common Stock M-Exempt	Sessa Capital (master), L.p. Director	Director	1 740 000 Value: $3.05M
Sep 29, 2025 Buy	Series B Convertible Preferred Stock M-Exempt	Sessa Capital (master), L.p. Director	Director	17 400 Value: $30.5K
Sep 29, 2025 Buy	Series B Convertible Preferred Stock M-Exempt	Sessa Capital (master), L.p. Director	Director	17 400 Value: $30.5K
Sep 29, 2025 Buy	Series B Convertible Preferred Stock M-Exempt	Moin Andrew Director	Director	17 400 Value: $30.5K
Sep 29, 2025 Buy	Common Stock M-Exempt	Sessa Capital (master), L.p. Director	Director	1 740 000 Value: $3.05M
Sep 29, 2025 Buy	Common Stock M-Exempt	Moin Andrew Director	Director	1 740 000 Value: $3.05M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks